Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer.

Jung W, Hong KD, Jung WY, Lee E, Shin BK, Kim HK, Kim A, Kim BH.

Korean J Pathol. 2013 Aug;47(4):332-9. doi: 10.4132/KoreanJPathol.2013.47.4.332. Epub 2013 Aug 26.

2.

Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.

Cha EJ, Noh SJ, Kwon KS, Kim CY, Park BH, Park HS, Lee H, Chung MJ, Kang MJ, Lee DG, Moon WS, Jang KY.

Clin Cancer Res. 2009 Jul 1;15(13):4453-9. doi: 10.1158/1078-0432.CCR-08-3329. Epub 2009 Jun 9.

3.

Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma.

Kang Y, Jung WY, Lee H, Lee E, Kim A, Kim BH.

Korean J Pathol. 2012 Dec;46(6):523-31. doi: 10.4132/KoreanJPathol.2012.46.6.523. Epub 2012 Dec 26.

4.

Expression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomas.

Kim JR, Moon YJ, Kwon KS, Bae JS, Wagle S, Yu TK, Kim KM, Park HS, Lee JH, Moon WS, Lee H, Chung MJ, Jang KY.

PLoS One. 2013 Sep 3;8(9):e74738. doi: 10.1371/journal.pone.0074738. eCollection 2013.

5.

Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.

Lee H, Kim KR, Noh SJ, Park HS, Kwon KS, Park BH, Jung SH, Youn HJ, Lee BK, Chung MJ, Koh DH, Moon WS, Jang KY.

Hum Pathol. 2011 Feb;42(2):204-13. doi: 10.1016/j.humpath.2010.05.023. Epub 2010 Nov 5.

PMID:
21056897
6.

Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.

Noh SJ, Kang MJ, Kim KM, Bae JS, Park HS, Moon WS, Chung MJ, Lee H, Lee DG, Jang KY.

Pathology. 2013 Oct;45(6):574-80. doi: 10.1097/PAT.0b013e3283652c7a.

PMID:
24018803
7.

Balance between SIRT1 and DBC1 expression is lost in breast cancer.

Sung JY, Kim R, Kim JE, Lee J.

Cancer Sci. 2010 Jul;101(7):1738-44. doi: 10.1111/j.1349-7006.2010.01573.x. Epub 2010 Mar 24.

8.

Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer.

Hiraike H, Wada-Hiraike O, Nakagawa S, Saji S, Maeda D, Miyamoto Y, Sone K, Tanikawa M, Oda K, Nakagawa K, Yano T, Fukayama M, Taketani Y.

Exp Ther Med. 2011 Nov;2(6):1105-1109. Epub 2011 Aug 12.

9.

Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.

Wangefjord S, Brändstedt J, Lindquist KE, Nodin B, Jirström K, Eberhard J.

Diagn Pathol. 2013 Jan 21;8:10. doi: 10.1186/1746-1596-8-10.

10.

DBC1 does not function as a negative regulator of SIRT1 in liver cancer.

Bae HJ, Chang YG, Noh JH, Kim JK, Eun JW, Jung KH, Kim MG, Shen Q, Ahn YM, Kwon SH, Park WS, Lee JY, Nam SW.

Oncol Lett. 2012 Nov;4(5):873-877. Epub 2012 Aug 23.

11.
12.

Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.

Tseng RC, Lee CC, Hsu HS, Tzao C, Wang YC.

Neoplasia. 2009 Aug;11(8):763-70.

13.

DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.

Zannini L, Buscemi G, Kim JE, Fontanella E, Delia D.

J Mol Cell Biol. 2012 Oct;4(5):294-303. doi: 10.1093/jmcb/mjs035. Epub 2012 Jun 26.

14.

DBC1 is over-expressed and associated with poor prognosis in colorectal cancer.

Zhang Y, Gu Y, Sha S, Kong X, Zhu H, Xu B, Li Y, Wu K.

Int J Clin Oncol. 2014 Feb;19(1):106-12. doi: 10.1007/s10147-012-0506-5. Epub 2013 Jan 9.

PMID:
23299276
15.

MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.

Pangon L, Mladenova D, Watkins L, Van Kralingen C, Currey N, Al-Sohaily S, Lecine P, Borg JP, Kohonen-Corish MR.

Int J Cancer. 2015 Jan 1;136(1):55-64. doi: 10.1002/ijc.28967. Epub 2014 May 27.

16.

Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line.

Chang E, Donahue J, Smith A, Hornick J, Rao JN, Wang JY, Battafarano RJ.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):225-32. doi: 10.1016/j.jtcvs.2009.11.038. Epub 2010 Mar 16.

17.

Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression.

Yu EJ, Kim SH, Kim HJ, Heo K, Ou CY, Stallcup MR, Kim JH.

Oncogene. 2016 Jun 30;35(26):3410-8. doi: 10.1038/onc.2015.401. Epub 2015 Oct 19.

PMID:
26477307
18.

Expression of Cyclin D1 Is Associated with β-Catenin Expression and Correlates with Good Prognosis in Colorectal Adenocarcinoma.

Jang KY, Kim YN, Bae JS, Chung MJ, Moon WS, Kang MJ, Lee DG, Park HS.

Transl Oncol. 2012 Oct;5(5):370-8. Epub 2012 Oct 1.

19.

SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer.

Noguchi A, Kikuchi K, Zheng H, Takahashi H, Miyagi Y, Aoki I, Takano Y.

Cancer Med. 2014 Dec;3(6):1553-61. doi: 10.1002/cam4.310. Epub 2014 Aug 21.

20.

Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.

Norwood MG, Bailey N, Nanji M, Gillies RS, Nicholson A, Ubhi S, Darnton JJ, Steyn RS, Womack C, Hughes A, Hemingway D, Harrison R, Waters R, Jankowski JA.

Histopathology. 2010 Jul;57(1):101-11. doi: 10.1111/j.1365-2559.2010.03587.x. Epub 2010 Jun 21.

PMID:
20572881
Items per page

Supplemental Content

Write to the Help Desk